Ausgabe 9/2011
Inhalt (8 Artikel)
A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
Robert H. Howland
Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder
Michael G. Oefelein
Effectiveness of Pharmacovigilance Training of General Practitioners
Roald Gerritsen, Hans Faddegon, Fred Dijkers, Kees van Grootheest, Eugène van Puijenbroek
Psychiatric Adverse Events Associated with Varenicline
Mira Harrison-Woolrych, Janelle Ashton
Mortality in Children and Adolescents Prescribed Antipsychotic Medication
Fariz A. Rani, Patrick Byrne, Noel Cranswick, Macey L. Murray, Ian C.K. Wong
Randomized Controlled Trials of COX-2 Inhibitors
Gudrun Stefansdottir, Marie L. De Bruin, Mirjam J. Knol, Diederick E. Grobbee, Hubert G.M. Leufkens